{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:24:51Z","timestamp":1751516691919},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00380-020-01609-w","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T09:02:37Z","timestamp":1588582957000},"page":"1349-1359","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship between adenosine A2a receptor polymorphism rs5751876 and fractional flow reserve during percutaneous coronary intervention"],"prefix":"10.1007","volume":"35","author":[{"given":"Matteo","family":"Nardin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Verdoia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Suryapranata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvin","family":"Khedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"1609_CR1","unstructured":"WHO (2019). https:\/\/apps.who.int\/gho\/data\/node.main. Accessed 25 Nov 2019"},{"key":"1609_CR2","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","volume":"356","author":"WE Boden","year":"2007","unstructured":"Boden WE, O\u2019Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GBJ, Weintraub WS (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503\u20131516","journal-title":"N Engl J Med"},{"key":"1609_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ahj.2018.04.011","volume":"201","author":"DJ Maron","year":"2018","unstructured":"Maron DJ, Hochman JS, O\u2019Brien SM, Reynolds HR, Boden WE, Stone GW, Bangalore S, Spertus JA, Mark DB, Alexander KP, Shaw L, Berger JS, Ferguson TB, Williams DO, Harrington RA, Rosenberg Y (2018) International study of comparative health effectiveness with medical and invasive approaches (ISCHEMIA) trial: rationale and design. Am Heart J 201:124\u2013135","journal-title":"Am Heart J"},{"key":"1609_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"F-J Neumann","year":"2018","unstructured":"Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet J-P, Falk V, Head SJ, J\u00fcni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovi\u0107 PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Wijns W, Glineur D, Aboyans V, Achenbach S, Agewall S, Andreotti F, Barbato E, Baumbach A, Brophy J, Bueno H, Calvert PA, Capodanno D, Davierwala PM, Delgado V, Dudek D, Freemantle N, Funck-Brentano C, Gaemperli O, Gielen S, Gilard M, Gorenek B, Haasenritter J, Haude M, Ibanez B, Iung B, Jeppsson A, Katritsis D, Knuuti J, Kolh P, Leite-Moreira A, Lund LH, Maisano F, Mehilli J, Metzler B, Montalescot G, Pagano D, Petronio AS, Piepoli MF, Popescu BA, S\u00e1daba R, Shlyakhto E, Silber S, Simpson IA, Sparv D, Tavilla G, Thiele H, Tousek P, Van Belle E, Vranckx P, Witkowski A, Zamorano JL, Roffi M, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet J-P, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, J\u00fcni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, McDonagh TA, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Sousa-Uva M, Simpson IA, Zamorano JL, Pagano D, Freemantle N, Sousa-Uva M, Chettibi M, Sisakian H, Metzler B, \u0130brahimov F, Stelmashok VI, Postadzhiyan A, Skoric B, Eftychiou C, Kala P, Terkelsen CJ, Magdy A, Eha J, Niemel\u00e4 M, Kedev S, Motreff P, Aladashvili A, Mehilli J, Kanakakis I-G, Becker D, Gudnason T, Peace A, Romeo F, Bajraktari G, Kerimkulova A, Rudz\u012btis A, Ghazzal Z, Kibarskis A, Pereira B, Xuereb RG, Hofma SH, Steigen TK, Witkowski A, de Oliveira EI, Mot S, Duplyakov D, Zavatta M, Beleslin B, Kovar F, Bunc M, Ojeda S, Witt N, Jeger R, Addad F, Akdemir R, Parkhomenko A, Henderson R (2018) 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J 40:87\u2013165","journal-title":"Eur Heart J"},{"key":"1609_CR5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/01.CIR.87.4.1354","volume":"87","author":"NH Pijls","year":"1993","unstructured":"Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL (1993) Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 87:1354\u20131367","journal-title":"Circulation"},{"key":"1609_CR6","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","volume":"49","author":"NHJ Pijls","year":"2007","unstructured":"Pijls NHJ, van Schaardenburgh P, Manoharan G, Boersma E, Bech J-W, van\u2019t Veer M, B\u00e4r F, Hoorntje J, Koolen J, Wijns W, de Bruyne B (2007) Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol 49:2105\u20132111","journal-title":"J Am Coll Cardiol"},{"key":"1609_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa0807611","volume":"360","author":"PAL Tonino","year":"2009","unstructured":"Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van\u2019t Veer M, Klauss V, Manoharan G, Engstr\u00f8m T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213\u2013224","journal-title":"N Engl J Med"},{"key":"1609_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00392-016-1010-0","volume":"105","author":"J R\u00f6ther","year":"2016","unstructured":"R\u00f6ther J, Achenbach S, Tr\u00f6bs M, Blachutzik F, Nef H, Marwan M, Schlundt C (2016) Comparison of standard- and high-dose intracoronary adenosine for the measurement of coronary fractional flow reserve (FFR). Clin Res Cardiol 105:1003\u20131010","journal-title":"Clin Res Cardiol"},{"key":"1609_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1161\/01.CIR.0000061950.24940.88","volume":"107","author":"B De Bruyne","year":"2003","unstructured":"De Bruyne B, Pijls NHJ, Barbato E, Bartunek J, Bech J-W, Wijns W, Heyndrickx GR (2003) Intracoronary and intravenous adenosine 5\u2032-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 107:1877\u20131883","journal-title":"Circulation"},{"key":"1609_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"J-F Chen","year":"2013","unstructured":"Chen J-F, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets\u2014what are the challenges? Nat Rev Drug Discov 12:265\u2013286","journal-title":"Nat Rev Drug Discov"},{"key":"1609_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/01.CIR.98.7.711","volume":"98","author":"JC Shryock","year":"1998","unstructured":"Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, Monopoli A, Ongini E, Baker SP, Belardinelli L (1998) A2A-adenosine receptor reserve for coronary vasodilation. Circulation 98:711\u2013718","journal-title":"Circulation"},{"key":"1609_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ijcard.2016.12.089","volume":"230","author":"V Gariboldi","year":"2017","unstructured":"Gariboldi V, Vairo D, Guieu R, Marlingue M, Ravis E, Lagier D, Mari A, Thery E, Collart F, Gaudry M, Bonello L, Paganelli F, Condo J, Kipson N, Fenouillet E, Ruf J, Mottola G (2017) Expressions of adenosine A2A receptors in coronary arteries and peripheral blood mononuclear cells are correlated in coronary artery disease patients. Int J Cardiol 230:427\u2013431","journal-title":"Int J Cardiol"},{"key":"1609_CR13","doi-asserted-by":"publisher","first-page":"E5964","DOI":"10.3390\/ijms20235964","volume":"20","author":"E Fenouillet","year":"2019","unstructured":"Fenouillet E, Mottola G, Kipson N, Paganelli F, Guieu R, Ruf J (2019) Adenosine receptor profiling reveals an association between the presence of spare receptors and cardiovascular disorders. Int J Mol Sci 20:E5964","journal-title":"Int J Mol Sci"},{"key":"1609_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajmg.b.30228","volume":"139B","author":"C Hohoff","year":"2005","unstructured":"Hohoff C, McDonald JM, Baune BT, Cook EH, Deckert J, de Wit H (2005) Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet 139B:42\u201344","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1609_CR15","first-page":"486","volume":"17","author":"X Chen","year":"2011","unstructured":"Chen X, Xue A, Chen W, Ding Y, Yan D, Peng J, Zeng C, Qu J, Zhou X (2011) Assessment of exonic single nucleotide polymorphisms in the adenosine A2A receptor gene to high myopia susceptibility in Chinese subjects. Mol Vis 17:486\u2013491","journal-title":"Mol Vis"},{"key":"1609_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.numecd.2010.08.005","volume":"22","author":"G De Luca","year":"2012","unstructured":"De Luca G, Secco GG, Santagostino M, Venegoni L, Iorio S, Cassetti E, Verdoia M, Coppo L, Di Mario C, Bellomo G, Marino P (2012) Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis 22:426\u2013433","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1609_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jcin.2011.08.004","volume":"4","author":"G De Luca","year":"2011","unstructured":"De Luca G, Venegoni L, Iorio S, Giuliani L, Marino P (2011) Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. JACC Cardiovasc Interv 4:1079\u20131084","journal-title":"JACC Cardiovasc Interv"},{"key":"1609_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2018.09.088","volume":"284","author":"M Verdoia","year":"2018","unstructured":"Verdoia M, Erbetta R, Sagazio E, Barbieri L, Negro F, Suryapranata H, Kedhi E, De Luca G, Novara Atherosclerosis Study Group (NAS) (2018) Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment. Int J Cardiol 284:16\u201321","journal-title":"Int J Cardiol"},{"key":"1609_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/0003319718768656","volume":"69","author":"M Verdoia","year":"2018","unstructured":"Verdoia M, Barbieri L, Kedhi E, Suryapranata H, De Luca G (2018) Percutaneous versus surgical revascularization for left main or multivessel coronary artery disease: results from a large-scale meta-analysis in the era of drug-eluting stents. Angiology 69:812\u2013824","journal-title":"Angiology"},{"key":"1609_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijcard.2017.06.022","volume":"244","author":"G De Luca","year":"2017","unstructured":"De Luca G, Smits P, Hofma SH, Di Lorenzo E, Vlachojannis GJ, van\u2019t Hof AWJ, van Boven AJ, Kedhi E, Stone GW, Suryapranata H (2017) Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Int J Cardiol 244:121\u2013127","journal-title":"Int J Cardiol"},{"key":"1609_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11239-014-1091-4","volume":"39","author":"G De Luca","year":"2015","unstructured":"De Luca G, Dirksen MT, Kelb\u00e6k H, Thuesen L, Vink MA, Kaiser C, Chechi T, Spaziani G, Di Lorenzo E, Suryapranata H, Stone GW (2015) Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. J Thromb Thrombolysis 39:101\u2013112","journal-title":"J Thromb Thrombolysis"},{"key":"1609_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1056\/NEJMoa1803538","volume":"379","author":"P Xaplanteris","year":"2018","unstructured":"Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, Engstr\u00f8m T, K\u00e4\u00e4b S, Dambrink J-H, Rioufol G, Toth GG, Piroth Z, Witt N, Fr\u00f6bert O, Kala P, Linke A, Jagic N, Mates M, Mavromatis K, Samady H, Irimpen A, Oldroyd K, Campo G, Rothenb\u00fchler M, J\u00fcni P, De Bruyne B (2018) Five-year Outcomes with PCI guided by fractional flow reserve. N Engl J Med 379:250\u2013259","journal-title":"N Engl J Med"},{"key":"1609_CR23","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jacc.2014.07.973","volume":"64","author":"NP Johnson","year":"2014","unstructured":"Johnson NP, T\u00f3th GG, Lai D, Zhu H, A\u00e7ar G, Agostoni P, Appelman Y, Arslan F, Barbato E, Chen S-L, Di Serafino L, Dom\u00ednguez-Franco AJ, Dupouy P, Esen AM, Esen \u00d6B, Hamilos M, Iwasaki K, Jensen LO, Jim\u00e9nez-Navarro MF, Katritsis DG, Kocaman SA, Koo B-K, L\u00f3pez-Palop R, Lorin JD, Miller LH, Muller O, Nam C-W, Oud N, Puymirat E, Rieber J, Rioufol G, Rod\u00e9s-Cabau J, Sedlis SP, Takeishi Y, Tonino PAL, Van Belle E, Verna E, Werner GS, Fearon WF, Pijls NHJ, De Bruyne B, Gould KL (2014) Prognostic value of fractional flow reserve. J Am Coll Cardiol 64:1641\u20131654","journal-title":"J Am Coll Cardiol"},{"key":"1609_CR24","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","volume":"376","author":"JE Davies","year":"2017","unstructured":"Davies JE, Sen S, Dehbi H-M, Al-Lamee R, Petraco R, Nijjer SS, Bhindi R, Lehman SJ, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, H\u00e4rle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Canas Silva P, Baptista SB, Alghamdi A, Hellig F, Koo B-K, Nam C-W, Shin E-S, Doh J-H, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J (2017) Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med 376:1824\u20131834","journal-title":"N Engl J Med"},{"key":"1609_CR25","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","volume":"376","author":"M G\u00f6tberg","year":"2017","unstructured":"G\u00f6tberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, Olsson S-E, \u00d6hagen P, Olsson H, Omerovic E, Calais F, Lindroos P, Maeng M, T\u00f6dt T, Venetsanos D, James SK, K\u00e5regren A, Nilsson M, Carlsson J, Hauer D, Jensen J, Karlsson A-C, Panayi G, Erlinge D, Fr\u00f6bert O (2017) Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med 376:1813\u20131823","journal-title":"N Engl J Med"},{"key":"1609_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jacc.2005.04.041","volume":"46","author":"A Berger","year":"2005","unstructured":"Berger A, Botman K-J, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, Pijls NHJ, De Bruyne B (2005) Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 46:438\u2013442","journal-title":"J Am Coll Cardiol"},{"key":"1609_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ccd.21406","volume":"71","author":"J Courtis","year":"2008","unstructured":"Courtis J, Rod\u00e9s-Cabau J, Larose E, D\u00e9ry J-P, Nguyen CM, Proulx G, Gleeton O, Roy L, Barbeau G, No\u00ebl B, DeLarochelli\u00e8re R, Bertrand OF (2008) Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements. Catheter Cardiovasc Interv 71:541\u2013548","journal-title":"Catheter Cardiovasc Interv"},{"key":"1609_CR28","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.amjcard.2014.03.004","volume":"113","author":"JP Depta","year":"2014","unstructured":"Depta JP, Patel JS, Novak E, Masrani SK, Raymer D, Facey G, Patel Y, Zajarias A, Lasala JM, Singh J, Bach RG, Kurz HI (2014) Outcomes of coronary stenoses deferred revascularization for borderline versus nonborderline fractional flow reserve values. Am J Cardiol 113:1788\u20131793","journal-title":"Am J Cardiol"},{"key":"1609_CR29","doi-asserted-by":"publisher","first-page":"e000431","DOI":"10.1136\/openhrt-2016-000431","volume":"4","author":"G Niccoli","year":"2017","unstructured":"Niccoli G, Indolfi C, Davies JE (2017) Evaluation of intermediate coronary stenoses in acute coronary syndromes using pressure guidewire. Open Hear 4:e000431","journal-title":"Open Hear"},{"key":"1609_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ahj.2004.04.008","volume":"148","author":"G Casella","year":"2004","unstructured":"Casella G, Leibig M, Schiele TM, Schrepf R, Seelig V, Stempfle H-U, Erdin P, Rieber J, K\u00f6nig A, Siebert U, Klauss V (2004) Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 148:590\u2013595","journal-title":"Am Heart J"},{"key":"1609_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1067\/mhj.2000.109920","volume":"140","author":"A Jeremias","year":"2000","unstructured":"Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, Yock PG (2000) Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 140:651\u2013657","journal-title":"Am Heart J"},{"key":"1609_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jcin.2011.12.014","volume":"5","author":"AM Leone","year":"2012","unstructured":"Leone AM, Porto I, De Caterina AR, Basile E, Aurelio A, Gardi A, Russo D, Laezza D, Niccoli G, Burzotta F, Trani C, Mazzari MA, Mongiardo R, Rebuzzi AG, Crea F (2012) Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc Interv 5:402\u2013408","journal-title":"JACC Cardiovasc Interv"},{"key":"1609_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2459\/JCM.0000000000000652","volume":"19","author":"S Gili","year":"2018","unstructured":"Gili S, Barbero U, Errigo D, De Luca G, Biondi-Zoccai G, Leone AM, Iannaccone M, Montefusco A, Omed\u00e9 P, Moretti C, D\u2019Amico M, Gaita F, D\u2019Ascenzo F (2018) Intracoronary versus intravenous adenosine to assess fractional flow reserve: a systematic review and meta-analysis. J Cardiovasc Med 19:274\u2013283","journal-title":"J Cardiovasc Med"},{"key":"1609_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/0735-1097(91)90795-B","volume":"18","author":"MJ Kern","year":"1991","unstructured":"Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC (1991) Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 18:718\u2013729","journal-title":"J Am Coll Cardiol"},{"key":"1609_CR35","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.CIR.82.5.1595","volume":"82","author":"RF Wilson","year":"1990","unstructured":"Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595\u20131606","journal-title":"Circulation"},{"key":"1609_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0002-8703(03)00120-0","volume":"146","author":"B Murtagh","year":"2003","unstructured":"Murtagh B, Higano S, Lennon R, Mathew V, Holmes DR, Lerman A (2003) Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. Am Heart J 146:99\u2013105","journal-title":"Am Heart J"},{"key":"1609_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.1135308","volume":"315","author":"C Kimchi-Sarfaty","year":"2007","unstructured":"Kimchi-Sarfaty C, Oh JM, Kim I-W, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM (2007) A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity. Science 315:525\u2013528","journal-title":"Science"},{"key":"1609_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijcard.2014.11.089","volume":"180","author":"R Guieu","year":"2015","unstructured":"Guieu R, Kipson N, Ruf J, Fournier N, Laine M, Foucher MC, Fromonot J, Mottola G, Bruzzese L, Boussuges A, Fenouillet E, Bonello L, Paganelli F (2015) Low basal expression of A2A adenosine receptors and increase in adenosine plasma concentration are associated with positive exercise stress testing. Int J Cardiol 180:15\u201317","journal-title":"Int J Cardiol"},{"key":"1609_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.euroneuro.2011.12.004","volume":"22","author":"C Beste","year":"2012","unstructured":"Beste C, Stock A-K, Ness V, Epplen JT, Arning L (2012) Differential effects of ADORA2A gene variations in pre-attentive visual sensory memory subprocesses. Eur Neuropsychopharmacol 22:555\u2013561","journal-title":"Eur Neuropsychopharmacol"},{"key":"1609_CR40","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/sj.npp.1300232","volume":"28","author":"K Alsene","year":"2003","unstructured":"Alsene K, Deckert J, Sand P, de Wit H (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28:1694\u20131702","journal-title":"Neuropsychopharmacology"},{"key":"1609_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.mp.4000345","volume":"3","author":"J Deckert","year":"1998","unstructured":"Deckert J, N\u00f6then MM, Franke P, Delmo C, Fritze J, Knapp M, Maier W, Beckmann H, Propping P (1998) Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3:81\u201385","journal-title":"Mol Psychiatry"},{"key":"1609_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/FPC.0b013e32803fb78f","volume":"17","author":"NP Riksen","year":"2007","unstructured":"Riksen NP, Franke B, van den Broek P, Smits P, Rongen GA (1976C) The 1976C%3eT polymorphism in the adenosine A2A receptor gene does not affect the vasodilator response to adenosine in humans in vivo. Pharmacogenet Genom 17:551\u2013554","journal-title":"Pharmacogenet Genom"},{"key":"1609_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/FPC.0b013e328347d2c6","volume":"21","author":"MG Andreassi","year":"2011","unstructured":"Andreassi MG, Laghi Pasini F, Picano E, Capecchi PL, Pompella G, Foffa I, Borghini A, Sicari R (2011) Adenosine A2(A) receptor gene polymorphism (1976C%3eT) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy. Pharmacogenet Genom 21:469\u2013475","journal-title":"Pharmacogenet Genom"},{"key":"1609_CR44","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/eurheartj\/ehp126","volume":"30","author":"AY Saadjian","year":"2009","unstructured":"Saadjian AY, Gerolami V, Giorgi R, Mercier L, Berge-Lefranc J-L, Paganelli F, Ibrahim Z, By Y, Gu\u00e9ant JL, L\u00e9vy S, Guieu RP (2009) Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism. Eur Heart J 30:1510\u20131515","journal-title":"Eur Heart J"},{"key":"1609_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phrs.2017.12.035","volume":"129","author":"M Nardin","year":"2018","unstructured":"Nardin M, Verdoia M, Pergolini P, Rolla R, Barbieri L, Marino P, Bellomo G, Kedhi E, Suryapranata H, Carriero A, De Luca G (2018) Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients. Pharmacol Res 129:27\u201333","journal-title":"Pharmacol Res"},{"key":"1609_CR46","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/sj.clpt.6100102","volume":"81","author":"JV R\u00e9tey","year":"2007","unstructured":"R\u00e9tey JV, Adam M, Khatami R, Luhmann UFO, Jung HH, Berger W, Landolt H-P (2007) A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther 81:692\u2013698","journal-title":"Clin Pharmacol Ther"},{"key":"1609_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/B978-0-12-801022-8.00015-5","volume":"119","author":"K Yamada","year":"2014","unstructured":"Yamada K, Kobayashi M, Kanda T (2014) Involvement of adenosine A2A receptors in depression and anxiety. Int Rev Neurobiol 119:373\u2013393","journal-title":"Int Rev Neurobiol"},{"key":"1609_CR48","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1038\/npp.2008.17","volume":"33","author":"E Childs","year":"2008","unstructured":"Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H (2008) Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33:2791\u20132800","journal-title":"Neuropsychopharmacology"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01609-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-020-01609-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01609-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T08:10:39Z","timestamp":1650528639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-020-01609-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1609"],"URL":"https:\/\/doi.org\/10.1007\/s00380-020-01609-w","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"25 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}